Merck Wave Analysis – 8 April 2025- Merck broke strong support level 81.30
- Likely to fall to support level 75.00
Merck is under bearish pressure after breaking the strong support level 81.30 (the former monthly low from February, which stopped the earlier impulse wave 1).
The breakout of the support level 81.30 should accelerate
Key facts today
Merck & Co. faces a class action lawsuit for alleged securities fraud over misleading revenue forecasts for Gardasil. Following a February 4, 2025 announcement, its stock dropped over 9%.
Merck & Co. has teamed up with Microsoft to integrate its medical resources into Microsoft's Copilot Studio, enhancing AI support for clinicians. Financial details remain undisclosed.
12,844.44
0.00 BRL
92.28 B BRL
344.88 B BRL
About Merck & Company, Inc.
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
ISIN
BRMRCKBDR003
FIGI
BBG0019P2RN5
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Merck & Co. (NYSE: $MRK) Sets Up Q125 Earnings Call for April 24Merck & Co. (NYSE: NYSE:MRK ) will hold its Q1 2025 earnings call on April 24 at 9:00 a.m. ET. Company executives will present financial results and performance updates during the call.
As of April 4th, 2025, MRK closed at $81.47, down $4.92 (5.70%). The stock has declined steadily since peaking at
How and When to switch from Selling Short to Buying Long Often times when the market is in a panic selling mode or trending down in a correction, stocks fall below their fundamental values. When that happens traders need to quickly close their sell short positions with buy to cover orders and prepare to start swing trading the velocity or momentum runs th
MRK 5M Long Investment Aggressive CounterTrend TradeAggressive CounterTrend Trade
- short impulse
+ exhaustion volume
+ volumed T1
+ volumed 2Sp-
+ weak test
+ first bullish bar closed entry
Calculated affordable stop limit
1/2 1M take profit
Hourly CounterTrend
"- short impulse
+ 1D SOS level"
Daily Trend
"+ long impulse
+ SOS level
- before 1/2
MRK to $98My trading plan is very simple.
I buy or sell when price tags the top or bottom of parallel channels.
I confirm when price hits Fibonacci levels.
So...
Here's why I'm picking this symbol to do the thing.
Price in channel zones at bottom of channels (period 100 52 & 26)
Stochastic Momentum Ind
Bounce Off the Bottom for Merck. MRKWe believe a downward impulse (Elliott) is finished and this is somewhat evident by the two candlestick price action. A change in the tone and flavor of candle sticks in momental OBOS area, overstretched VZO/StochRSI combo can be suggestive of a pivot and we believe this to be happening here. If the
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050Yield to maturity
7.57%
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061Yield to maturity
7.28%
Maturity date
Dec 10, 2061
US58933YBF1
MERCK & CO. 21/51Yield to maturity
7.16%
Maturity date
Dec 10, 2051
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042Yield to maturity
6.77%
Maturity date
Sep 15, 2042
US58933YBA2
MERCK & CO. 20/40Yield to maturity
6.65%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045Yield to maturity
6.50%
Maturity date
Feb 10, 2045
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049Yield to maturity
6.35%
Maturity date
Mar 7, 2049
US58933YAJ4
MERCK CO. 13/43Yield to maturity
6.28%
Maturity date
May 18, 2043
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063Yield to maturity
6.01%
Maturity date
May 17, 2063
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053Yield to maturity
5.98%
Maturity date
May 17, 2053
US58933YAV7
MERCK & CO. 19/39Yield to maturity
5.93%
Maturity date
Mar 7, 2039
See all MRCK34 bonds
Curated watchlists where MRCK34 is featured.